NL-OMON33122已完成不适用
Adherence and patients' experiences with the use of erlotinib in NSCLC treatment: The influence on plasma concentration and the exploration of factors affecting the use in daily practice - Adherence and patients* experiences with erlotinib
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •NSCLC patients starting with erlotinib
排除标准
- •younger than 18 year
研究者
相似试验
已完成
不适用
Adherence and patients' experiences with the use of capecitabine in cancer treatment: The exploration of factors affecting the use in daily practicecolorectal cancergastric cancer and breast cancer10017991NL-OMON36444Vrije Universiteit Medisch Centrum90
已完成
不适用
Treatment persistence and adherence in patients with Parkinson's disease in Japan: a retrospective observational study using health insurance claim databasesParkison's diseaseJPRN-UMIN000052869Eisai Co., Ltd.
招募中
Unknown
Impact on adherence to treatment of patients with Diabetes at the basic health unit with telephone follow-up: a randomized clinical trialDiabetes Mellitus, Type 2C18.452.394.750RBR-10nsmwztniversidade Federal de São Paulo
已完成
不适用
A Comparison of Patient Adherence and Preference of Packaging Method for Oral Anticancer Agents Using Conventional Pill Bottles versus Daily Pill BoxesAdvanced solid tumorsSolid tumoursCancerISRCTN74558413Princess Margaret Hospital (Canada)25
已完成
不适用
Adherence and patients’ experiences with capecitabine.Colorectal cancer, gastric cancer and breast cancer.NL-OMON21382VU University Medical Center66